Clinical trial

Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

NCT02787798

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention valsartan/sacubitril 100 mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention valsartan/sacubitril 200 mg Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Microneurography Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-10-01

PhasePHASE4

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

valsartan/sacubitril 100 mgDRUG

valsartan/sacubitril 200 mgDRUG

MicroneurographyPROCEDURE

Sponsors & collaborators

University Hospital, Toulouselead sponsor

Mapped research locations

ToulouseFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02787798 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.